Esther Hong
Stock Analyst at Loop Capital
(n/a)
# 4,708
Out of 5,156 analysts
15
Total ratings
9.09%
Success rate
-38.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Hong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI AtaiBeckley | Initiates: Buy | $18 | $3.89 | +362.72% | 2 | Nov 1, 2022 | |
| ACAD ACADIA Pharmaceuticals | Initiates: Hold | $17 | $22.58 | -24.71% | 2 | Nov 1, 2022 | |
| CMPS COMPASS Pathways | Initiates: Buy | $34 | $6.86 | +395.63% | 1 | Nov 1, 2022 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $95 | $164.49 | -42.25% | 2 | Nov 1, 2022 | |
| SPRO Spero Therapeutics | Downgrades: Hold | $2 | $2.32 | -13.79% | 2 | May 20, 2022 | |
| APRE Aprea Therapeutics | Downgrades: Hold | n/a | $0.84 | - | 2 | Aug 16, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $32 | $5.26 | +508.37% | 4 | Dec 16, 2020 |
AtaiBeckley
Nov 1, 2022
Initiates: Buy
Price Target: $18
Current: $3.89
Upside: +362.72%
ACADIA Pharmaceuticals
Nov 1, 2022
Initiates: Hold
Price Target: $17
Current: $22.58
Upside: -24.71%
COMPASS Pathways
Nov 1, 2022
Initiates: Buy
Price Target: $34
Current: $6.86
Upside: +395.63%
Axsome Therapeutics
Nov 1, 2022
Initiates: Buy
Price Target: $95
Current: $164.49
Upside: -42.25%
Spero Therapeutics
May 20, 2022
Downgrades: Hold
Price Target: $2
Current: $2.32
Upside: -13.79%
Aprea Therapeutics
Aug 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $0.84
Upside: -
Aldeyra Therapeutics
Dec 16, 2020
Initiates: Buy
Price Target: $32
Current: $5.26
Upside: +508.37%